Neural Differentiation and Apoptosis in Glioblastoma Driven by GQIcombi: Evidence from RNA-seq Analysis.

Authors

Varvara Kolesnikova, Ksenia Rubetskaya, Fatima Dzarieva, Dmitry Usachev, Galina Pavlova

Published in

Current neuropharmacology. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

Glioblastoma is one of the most common and aggressive primary brain tumors in adults, and remains universally incurable. Due to the cellular heterogeneity of glioblastoma, the development of effective therapies remains a pressing and as-yet-unsolved challenge. Transcriptomic profiling provides a powerful approach to delineate molecular perturbations induced by candidate therapeutic compounds.
In the present study, a comprehensive transcriptome analysis of human glioblastoma cells following exposure to GQIcombi, a multifactorial combination with demonstrated antiproliferative and neurodifferentiation-promoting activities previously established in grade 2-4 glioma cell cultures, was performed.
Comprehensive pathway targeting creates a synergistic anti-tumor effect, simultaneously disrupting proliferation, survival, and invasion, while inducing programmed cell death.
The multi-level approach prevents compensatory activation and overcomes inherent treatment resistance in glioblastoma cells.
The study's investigation focused on essential signaling pathways that maintain tumor cell homeostasis, thus revealing potential mechanisms underlying GQIcombi's antitumor activity.

PMID:
42865178
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.